In a new assignment from a new client Aagami is now poised to support licensing or acquisition of the first and only oral contraceptive specifically d...
Published : 14 Feb 2018
Read MoreAagami received a renewal of annual contract for another year from its client.Client is an independent global Contract Research Organization (CRO) off...
Published : 27 Oct 2017
Read MoreIn September 2017, Aagami completed a busy and fruitful BioPharm America (BPA) 2017 conference with over 50 meetings. Dinesh Jain, CEO Aagami attended...
Published : 01 Oct 2017
Read MoreHappy with previous assignments delivered by Aagami, its Netherlands HQ'd client has given Aagami a broader and long term assignment, for partnering i...
Published : 20 Sep 2017
Read MoreAagami team are happy to anounced that their Louisiana based Biotechnology client have given another assignment (3rd from them) to sup...
Published : 08 Aug 2017
Read MoreThis time, Aagami has a new client from South Korea. The recent trips to the country has been fruitful. Apart from this new assignment, more are in di...
Published : 02 Jun 2017
Read MoreAnother day, Another assignment for Aaagami. Client is a high growth US MedTech, advancing the next generation of affordable, portable, minimally inva...
Published : 15 May 2017
Read MoreAagami has received a new assignment from a new client for strategic advisory and partnership development.Client is a bio-targeted nanomedicines ...
Published : 06 May 2017
Read MoreAagami announces a new client win. Aagami has received a mandate for strategic advisory and cross border licensing partnering.The UK based clien...
Published : 15 Apr 2017
Read MoreIn keeping up with the annual tradition, Aagami is participating in JP Morgan Healthcare conference and BioTech Showcase this January 2017. Both ...
Published : 09 Nov 2016
Read More